Atlas Trials

The Moderating Role of Baseline Oxytocin on Its Psychotherapy-facilitating Effects Among Patients With Eating Disorders

Clinical trial NCT05865288 · UNKNOWN

Trial details

NCT number
NCT05865288
Sponsor
Shalvata Mental Health Center
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Eating Disorders
Start date
2023-06-30
Primary completion
2024-04-30
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.